361443-82-5—Key glycopeptide tools for glycoprotein research and drug discovery

Agalactoglycopeptide is a class of precisely designed glycopeptide compounds. Its structural feature is that a specific oligosaccharide chain is connected to the peptide chain, and the sugar chain lacks a terminal galactose group. As an important tool molecule in the field of glycoprotein research and glycobiology, it provides a unique chemical and biological entry point for revealing the fine functions of glycosylation modifications and developing innovative therapies targeting sugar-protein interactions.

Chemical Information

Chemical name: Agalactoglycopeptide

Common name: Agalactoglycopeptide

Chemical formula: C78H135N13O44

Molecular weight: 1958.99 g/mol

CAS number: 361443-82-5

Category: SGP Products

Structural features

The core value of Agalactoglycopeptide lies in its carefully constructed sugar-peptide complex structure, which has the following distinctive characteristics:

l Precise glycoform structure: The molecule contains a clear peptide backbone, on which oligosaccharide chains of known sequence and connection method are connected through specific glycosidic bonds. The key feature of this oligosaccharide chain is the lack of galactose residues at its non-reducing end, a structural detail that mimics the glycoform state of glycoproteins in specific biological processes (such as certain congenital glycosylation disorders or after engineering modification).

l Stable glycopeptide connection: The sugar chain is connected to specific amino acids on the peptide chain (usually asparagine, forming an N-link) through stable chemical bonds, ensuring the integrity of the molecule under a variety of experimental conditions and providing a reliable basis for in vitro and cell research.

l Functional site accessibility: The galactose-free terminal structure allows it to be specifically recognized by certain lectins (such as Galanthus nivalis lectin, GNL) or antibodies, while also avoiding binding by galactose-specific receptors (such as asialoglycoprotein receptor, ASGPR). This feature is crucial in targeting research.

Main applications and advantages

1. Core probes for glycobiology and glycoprotein functional studies

Mechanism analysis tool: This molecule is an ideal model compound for studying protein glycosylation modifications, especially how N-linked sugar chains affect protein folding, stability, intracellular transport and activity. Its clear chemical structure helps establish structure-activity relationships at the molecular level.

Interaction research: As a ligand, it is used to study the specific recognition and binding mechanism between sugar-binding proteins (such as lectins, antibodies, cell surface receptors) and specific glycoforms (here, galactose-free forms). It can be used to determine binding affinity and map binding epitopes.

2. Tool antigens for immunology and autoimmune disease research

Antibody characterization: In the study of autoimmune diseases, specific galactose-free glycoprotein structures serve as self-antigenic epitopes. Agalactoglycopeptide can be used to generate or detect antibodies against such modified epitopes (such as the anti-filaggrin antibody subtype in rheumatoid arthritis), which is helpful for the development of disease diagnostic markers and the exploration of pathological mechanisms.

B cell and T cell response research: As a clear glycopeptide antigen, it can be used to explore the recognition, presentation and elicitation of specific immune responses to glycosylated modified peptides by the immune system, providing a theoretical basis for the design of vaccines or immune modulators based on glycopeptides.

3. The starting point of drug discovery and biotechnology development

Lead compound and targeting carrier: Its structure can be used as a skeleton for designing drug carriers or lead compounds targeting specific lectins or receptors. Through further chemical modification, its pharmacokinetic properties can be optimized or new functions can be given to it.

Enzyme activity assay and inhibitor screening: As natural substrate analogues for specific glycosyltransferases (such as β-1,4-galactosyltransferase responsible for adding galactose), it can be used to develop enzyme activity detection methods, or as the molecular basis for competitive inhibitor screening to discover potential drugs that modulate the glycosylation process.

Quality control standard: In the development and production process of glycoprotein drugs (such as monoclonal antibodies), it can be used as a reference standard or control substance for related glycoform analysis (such as monitoring the galactose content in the Fc region of the antibody, which affects antibody-dependent cell-mediated cytotoxicity and ADCC effect).

Conclusion

With its clear structure and specific functions, Agalactoglycopeptide has become a bridge connecting chemical synthesis, basic research on glycobiology and translational medicine applications. From deciphering the delicate sugar code of life to facilitating the development of a new generation of glycosylation-specific diagnostic tools and targeted therapies, this molecule has demonstrated continued and important value in advancing the development of the frontiers of biomedicine.

The above information is provided by the editor of KASONS and is for scientific research only.